Your browser doesn't support javascript.
loading
Cutting Balloon Angioplasty for Severe In-Stent Restenosis after Carotid Artery Stenting: Long-Term Outcomes and Review of Literature.
Lee, Jeong-Yoon; Kye, Min-Surk; Kim, Jonguk; Kim, Do Yeon; Kim, Jun Yup; Baik, Sung Hyun; Kang, Jihoon; Kim, Beom Joon; Bae, Hee-Joon; Jung, Cheolkyu.
Afiliación
  • Lee JY; Department of Neurology, Soonchunhyang University Seoul Hospital, Seoul, Korea.
  • Kye MS; Department of Translational Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Kim J; Seoul Singil Rehabilitation Clinic, Seoul, Korea.
  • Kim DY; Department of Translational Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Kim JY; Department of Neurology, Inha University Hospital, Incheon, Korea.
  • Baik SH; Department of Neurology, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Kang J; Department of Neurology, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Kim BJ; Department of Radiology, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Bae HJ; Department of Neurology, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Jung C; Department of Neurology, Seoul National University Bundang Hospital, Seongnam, Korea.
Neurointervention ; 19(1): 24-30, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38321887
ABSTRACT

PURPOSE:

Cutting balloon-percutaneous transluminal angioplasty (CB-PTA) is a feasible treatment option for in-stent restenosis (ISR) after carotid artery stenting (CAS). However, the longterm durability and safety of CB-PTA for ISR after CAS have not been well established. MATERIALS AND

METHODS:

We retrospectively reviewed medical records of patients with ISR after CAS who had been treated with CB-PTA from 2012 to 2021 in our center. Detailed information of baseline characteristics, periprocedural and long-term outcomes, and follow-up imaging was collected.

RESULTS:

During 2012-2021, a total of 301 patients underwent CAS. Of which, CB-PTA was performed on 20 lesions exhibiting severe ISR in 18 patients following CAS. No patient had any history of receiving carotid endarterectomy or radiation therapy. These lesions were located at the cervical segment of the internal carotid artery (n=16), proximal external carotid artery (n=1), and distal common carotid artery (n=1). The median time interval between initial CAS and detection of ISR was 390 days (interquartile range 324-666 days). The follow-up period ranged from 9 months to 9 years with a median value of 21 months. Four patients (22.2%) were symptomatic. The average of stenotic degree before and after the procedure was 79.2% and 34.7%, respectively. Out of the 18 patients receiving CB-PTA, 16 (88.9%) did not require additional stenting, and 16 (88.9%) did not experience recurrent ISR during the follow-up period. Two patients who experienced recurrent ISR were successfully treated with CB-PTA and additional stenting. No periprocedural complication was observed in any case.

CONCLUSION:

Regarding favorable periprocedural and long-term outcomes in our single-center experience, CB-PTA was a feasible and safe option for the treatment of severe ISR after CAS.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Neurointervention Año: 2024 Tipo del documento: Article Pais de publicación: Corea del Sur
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Neurointervention Año: 2024 Tipo del documento: Article Pais de publicación: Corea del Sur